codexis.com (CDXS): Long-Term Debt to Capital Ratio

Brandmark of Codexis (CDXS)

The daily price chart for Codexis, Inc. (CDXS) confirms the resilience of cash flow from multi-year deals with healthcare behemoths, where the indicator stands at 1.92. Revenues are based on protein sales and the licensing of catalysts for the chemical industry. Business development relies on alliances with global corporations utilizing the CodeEvolver system for the rapid engineering of unique enzymes.

codexis.com (CDXS): Long-Term Debt to Capital from 07/04/2022 to 10/27/2026

Metric breakdowns and analytics for Codexis Inc (CDXS)

- price and consensus price forecast:
Share Price Codexis Bio|CDXS - Price Target Chart
- market capitalization data:
Market Capitalization Codexis|CDXS - Enterprise Value
- book capitalization data:
Book Value per Share Codexis, Inc.|CDXS - Book Capitalization|Market Cap to Net Assets Ratio codexis.com|CDXS - Aggregate Company Assets
- debt and liquidity data:
Debt to Capital Codexis, Inc.|CDXS - Long-Term Debt to Capital|Short-Term Debt to Capital Ratio Codexis Bio|CDXS - Company Aggregate Debts|Debts to Book Value Codexis
Summary company analytics:CDXS codexis.com
Core merchandise of codexis.com

Analyzing the ratio of long-term liabilities to equity for Codexis, Inc. (CDXS) allows for an assessment of the company's financial stability within the context of scaling biocatalyst production. This ratio compares loans with maturities exceeding one year against equity, identifying risks of over-leverage or inefficient resource utilization during the expansion of pharmaceutical industry partnerships, which confirms the overall strength of the issuer's balance sheet structure.

Competitors of Codexis, Inc.

Long-Term Debt to Capital Ratio TEM|Long-Term Debt to Equity Qiagen Group QGEN|Long-Term Debt to Capital Ratio Isis Pharmaceuticals (IONS)|Long-Term Debt to Capital RGEN (Repligen Corporation)|Long-Term Debt to Capital aviditybiosciences.com RNA|CRSP: Long-Term Debt to Capital|WGS: Long-Term Debt to Equity Ratio|Long-Term Debt to Equity RARE|Beam Tx (BEAM) - Long-Term Liabilities to Capital|Long-Term Debt to Capital Sarepta Therapeutics, Inc. (SRPT)|Long-Term Debt to Capital Ratio twistbioscience.com|10x Genomics - Long-Term Debt to Capital|Long-Term Liabilities to Capital Intellia Therapeutics Inc NTLA|STOK - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital Ratio BioLife BLFS|Long-Term Debt to Capital WVE (Wave Life Sciences)|MAZE: Ratio of Long-Term Indebtedness to Capital|Sionna Therapeutics - Long-Term Debt to Equity|Ratio of Long-Term Indebtedness to Capital Prime Medicine Inc|TSHA - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital Coefficient uniQure Pharma|MGTX (MeiraGTx Holdings plc) - Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital RGNX (regenxbio.com)|SLDB - Long-Term Debt to Equity|Long-Term Debt to Capital Ratio Ocugen Inc OCGN|PACB: Long-Term Debt to Capital|Benitec Corp (BNTC) - Long-Term Debt to Equity Ratio|Design Therapeutics - Long-Term Debt to Equity Ratio|rocketpharma.com (RCKT) - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Capital FDMT|Long-Term Debt to Equity Ratio Lexeo|Long-Term Debt to Capital Korro Bio, Inc. KRRO|Long-Term Debt to Capital Ratio Editas Corp EDIT|SLN - Long-Term Debt to Equity Ratio|ProQR - Long-Term Debt to Capital Ratio|Long-Term Debt to Equity SGMO (Sangamo Therapeutics, Inc.)|NAUT - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Capital Metagenomi, Inc|DTIL (Precision BioSciences Inc.) - Long-Term Debt to Capital Ratio|Long-Term Debt to Equity Generation Bio Co (GBIO)|Long-Term Debt to Capital Ratio boundlessbio.com|Long-Term Debt to Capital XCUR|Long-Term Debt to Capital imunon.com (IMNN)|Phio Pharmaceuticals Corp. - Long-Term Debt to Capital|Mustang Bio Inc - Long-Term Debt to Equity Ratio|RNAZ (TransCode) - Long-Term Debt to Equity|BNGO - Long-Term Liabilities to Capital|Long-Term Debt to Capital Applied DNA Sciences, Inc.|bluebird bio Inc. (BLUE) - Long-Term Debt to Capital Ratio|Long-Term Debt to Capital IPA (ImmunoPrecise Antibodies Ltd)|Long-Term Liabilities to Capital Omega Therapeutics Corp (OMGA)|Long-Term Debt to Equity Ratio Singular Genomics Systems OMIC|Long-Term Debt to Capital Ratio regulusrx.com (RGLS)|Long-Term Debt to Capital SYRS|Telesis Bio Inc. - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity TCON (TRACON)|Unity Biotechnology, Inc (UBX) - Ratio of Long-Term Indebtedness to Capital